Considering the treatment strategy of SPS and anti-GAD65 antibody, it was finally decided to add intravenous immunoglobulin (IVIG) (0.4 g/kg) to the existing APS treatment regimen for a period of 7 days of immunomodulatory therapy. Here, GAD2 is linked to stiff-person syndrome.